4D Molecular Therapeutics Inc.
FDMT | NASDAQ
$15.61
+$0.37 (+2.43%)
Sep 22, 2026, 9:49 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.78M | 3.05M | 85.09M | 90K | 15K | 14K | 1K | 3K | 5K | 28K | -19K | 20.2M | 239K | 298K | 1.25M | 500K | 162K | 1.22M | 92K | 1.37M | 14.58M | 2M |
Cost of Revenue | n/a | 2.06M | 1.98M | 47.24M | 47.95M | 40.7M | 1.78M | 38.48M | 31.86M | 27.87M | 26.03M | 25.07M | 23.58M | 22.41M | 21.5M | 18.94M | 20.42M | 19.38M | 17.53M | 15.84M | 15.22M | 12.77M |
Gross Profit | 3.78M | 992K | 83.11M | -47.15M | -47.94M | -40.69M | -1.78M | -38.48M | -31.86M | -27.84M | -26.05M | -4.86M | -23.35M | -22.11M | -20.25M | -18.44M | -20.26M | -18.16M | -17.44M | -14.47M | -643K | -10.77M |
Operating Income | -77.03M | -73.62M | 14.72M | -61.19M | -59.46M | -53.62M | -56.12M | -51.13M | -42.46M | -38.14M | -36.65M | -13.97M | -32.14M | -30.11M | -28.72M | -26.5M | -28.43M | -26.39M | -24.76M | -22.66M | -7.6M | -16.31M |
Interest Income | 4.26M | 4.86M | 4.7M | 4.33M | 4.86M | 5.58M | 6.47M | 7.29M | 7.55M | 5.75M | 4.38M | 3.88M | 2.51M | 1.44M | 1.34M | 795K | 340K | 100K | n/a | 435K | 7K | 7K |
Pretax Income | -72.94M | -68.76M | 19.4M | -56.88M | -54.66M | -47.97M | -49.67M | -43.84M | -34.95M | -32.4M | -32.28M | -10.26M | -29.62M | -28.68M | -27.38M | -25.69M | -28.09M | -26.34M | -25.08M | -22.24M | -7.59M | -16.41M |
Net Income | -72.94M | -68.76M | 19.4M | -56.88M | -54.66M | -47.97M | -49.67M | -43.84M | -34.95M | -32.4M | -32.28M | -10.26M | -29.62M | -28.68M | -27.38M | -25.69M | -28.09M | -26.34M | -25.08M | -22.24M | -7.59M | -16.41M |
Selling & General & Admin | 12.52M | 11.69M | 12.77M | 11.84M | 11.52M | 12.94M | 14.63M | 12.65M | 10.6M | 10.29M | 10.61M | 9.11M | 8.79M | 7.99M | 8.47M | 8.06M | 8.17M | 8.23M | 7.33M | 8.19M | 6.95M | 5.54M |
Research & Development | 68.28M | 64.98M | 57.61M | 49.44M | 47.95M | 40.7M | 43.09M | 38.48M | 31.86M | 27.87M | 26.03M | 25.07M | 23.58M | 22.41M | 21.5M | 18.94M | 20.42M | 19.38M | 17.53M | 15.84M | 15.22M | 12.77M |
Other Expenses | n/a | -2.06M | -1.98M | -47.24M | -47.95M | -40.7M | -3.38M | -38.48M | -31.86M | -27.87M | -26.03M | -25.07M | -23.58M | -22.41M | -21.5M | -18.94M | -20.42M | -19.38M | -17.53M | -15.84M | -15.22M | -12.77M |
Operating Expenses | 80.81M | 74.61M | 68.4M | 14.04M | 11.52M | 12.94M | 54.33M | 12.65M | 10.6M | 10.29M | 10.61M | 9.11M | 8.79M | 7.99M | 8.47M | 8.06M | 8.17M | 8.23M | 7.33M | 8.19M | 6.95M | 5.54M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 312K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 1.59M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 80.81M | 76.67M | 70.38M | 61.28M | 59.47M | 53.64M | 56.12M | 51.14M | 42.46M | 38.16M | 36.63M | 34.18M | 32.38M | 30.4M | 29.97M | 27M | 28.59M | 27.61M | 24.86M | 24.03M | 22.18M | 18.31M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 70.27M | 68.06M | 57.93M | 56.13M | 55.93M | 55.74M | 53.94M | 55.55M | 55.28M | 49.27M | 39.13M | 42.26M | 38.34M | 32.72M | 32.49M | 32.39M | 32.28M | 32.23M | 27.02M | 27.02M | 26.74M | 26.69M |
Shares Outstanding (Diluted) | 70.27M | 68.06M | 57.93M | 56.13M | 55.93M | 55.74M | 53.94M | 55.55M | 55.28M | 49.27M | 39.13M | 42.26M | 38.34M | 32.72M | 32.49M | 32.39M | 32.32M | 32.23M | 27.02M | 27.02M | 26.74M | 26.69M |
EPS (Basic) | -1.04 | -1.01 | 0.34 | -1.01 | -0.98 | -0.86 | -0.90 | -0.79 | -0.63 | -0.66 | -0.83 | -0.24 | -0.77 | -0.83 | -0.84 | -0.74 | -0.85 | -0.81 | -0.93 | -0.82 | -0.28 | -0.61 |
EPS (Diluted) | -1.04 | -1.01 | 0.34 | -1.01 | -0.98 | -0.86 | -0.90 | -0.79 | -0.63 | -0.66 | -0.83 | -0.24 | -0.77 | -0.83 | -0.84 | -0.74 | -0.85 | -0.81 | -0.93 | -0.82 | -0.28 | -0.61 |
EBITDA | -76.86M | -66.71M | 12.39M | -55.62M | -53.49M | -46.22M | -47.89M | -42.14M | -33.76M | -31.23M | -31.18M | -9.26M | -28.54M | -27.65M | -26.37M | -25.17M | -27.62M | -25.93M | -24.38M | -21.86M | -7.22M | -15.93M |
EBIT | -76.86M | -68.76M | 10.41M | -56.88M | -54.66M | -47.97M | -49.67M | -43.84M | -34.95M | -32.4M | -32.28M | -10.26M | -29.62M | -28.68M | -27.38M | -25.69M | -28.09M | -26.34M | -24.77M | -22.24M | -7.59M | -16.31M |
Depreciation & Amortization | n/a | 2.06M | 1.98M | 1.26M | 1.17M | 1.75M | 1.78M | 1.7M | 1.19M | 1.17M | 1.1M | 994K | 1.08M | 1.03M | 1.01M | 517K | 466K | 406K | 390K | 380K | 370K | 383K |
Add to Watchlist
Select watchlists to add or remove FDMT